 | Up a level |
2022
Vehreschild, Maria J. G. T., Ducher, Annie, Louie, Thomas, Cornely, Oliver A. 
ORCID: 0000-0001-9599-3137, Feger, Celine, Dane, Aaron, Varastet, Marina, Vitry, Fabien, de Gunzburg, Jean, Andremont, Antoine, Mentre, France ORCID: 0000-0002-7045-1275 and Wilcox, Mark H.
(2022).
An open randomized multicentre Phase 2 trial to assess the safety of DAV132 and its efficacy to protect gut microbiota diversity in hospitalized patients treated with fluoroquinolones.
J. Antimicrob. Chemother., 77 (4).
S. 1155 - 1166.
OXFORD:
OXFORD UNIV PRESS.
ISSN 1460-2091
2021
van Prehn, Joffrey, Reigadas, Elena, Vogelzang, Erik H., Bouza, Emilio, Hristea, Adriana, Guery, Benoit, Krutova, Marcela, Noren, Torbjorn, Allerberger, Franz, Coia, John E., Goorhuis, Abraham, van Rossen, Tessel M., Ooijevaar, Rogier E., Burns, Karen, Olesen, Bente R. Scharvik, Tschudin-Sutter, Sarah, Wilcox, Mark H., Vehreschild, Maria J. G. T., Fitzpatrick, Fidelma and Kuijper, Ed J. (2021). European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults. Clin. Microbiol. Infect., 27. S. S1 - 21. OXFORD: ELSEVIER SCI LTD. ISSN 1469-0691
2020
Guery, Benoit, Georgopali, Areti, Karas, Andreas, Kazeem, Gbenga, Michon, Ingrid, Wilcox, Mark H. and Cornely, Oliver A. (2020). Pharmacokinetic analysis of an extended-pulsed fidaxomicin regimen for the treatment of Clostridioides (Clostridium) difficile infection in patients aged 60 years and older in the EXTEND randomized controlled trial. J. Antimicrob. Chemother., 75 (4). S. 1014 - 1019. OXFORD: OXFORD UNIV PRESS. ISSN 1460-2091